http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022132046-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_266f27c9e90e00b1173c45726524c540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dded61bd89f99900518597c0958b9a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
filingDate 2021-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b32595fe1a9bb2718a93582fd9a97c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_271ce726eee83e5fb6a84614ec18c6e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71abe416a8e278cda8c06623d40f63f2
publicationDate 2022-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022132046-A1
titleOfInvention Improved process for preparing osimertinib or a salt thereof
abstract Provided herein are improved processes and methods for preparing osimertinib or a salt thereof, in particular osimertinib mesylate. The improved process removes the necessity of isolating the unstable aniline intermediate of formula (III) and enables the direct coupling to form the amide product of formula (II): The present invention is suitable for a large-scale production, avoiding the isolation of unstable intermediate, thereby providing osimertinib or a mesylate salt thereof in both high yields and high purity.
priorityDate 2020-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017134051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013014448-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239637184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57429072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228988413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID354011909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71496458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71239349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78358313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132037770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239637404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239637212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239637650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86677269

Total number of triples: 55.